Bart J Biemond
Overview
Explore the profile of Bart J Biemond including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
3028
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brandsen R, Biemond B, Nur E, Chang-Wolf J, Schlingemann R, Diederen R
Retina
. 2025 Jan;
PMID: 39761517
Purpose: To evaluate the presence and progression of maculopathy in patients with sickle cell disease (SCD) using Optical Coherence Tomography (OCT) and OCT-Angiography (OCTA), and to identify clinical/laboratory risk factors...
2.
Tang M, Van der Tuin D, Aydin M, Heijmans J, van de Loosdrecht A, Meijer E, et al.
Eur J Haematol
. 2024 Dec;
114(4):620-625.
PMID: 39726233
Background: Relapsed acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) are associated with a poor prognosis. It is unknown which re-induction therapy provides the highest chance of durable remission....
3.
Brandsen R, Diederen R, Kocabas G, Nur E, Malekzadeh A, Schlingemann R, et al.
Haematologica
. 2024 Dec;
PMID: 39704162
Sickle cell retinopathy (SCR) is a complication of sickle cell disease (SCD) and can drastically impair visual acuity. Screening for SCR is therefore recommended, but evidence for optimal screening frequency...
4.
Gaartman A, Beuger B, de Ligt L, Veldthuis M, Matlung H, Meijers J, et al.
Br J Haematol
. 2024 Dec;
206(3):1010-1013.
PMID: 39639778
No abstract available.
5.
van Wonderen S, van Baarle F, Tuip-de Boer A, Polet C, van Bruggen R, Vermeulen C, et al.
Res Pract Thromb Haemost
. 2024 Dec;
8(8):102612.
PMID: 39634321
Background: Platelet increment is reportedly lower for maximum stored platelet concentrates (PCs) and during pyrexia, and function differs between fresh and stored PCs. However, little is known about the function...
6.
Afzali-Hashemi L, Baas K, Schrantee A, Nur E, Vu C, Choi S, et al.
Hemasphere
. 2024 Dec;
8(12):e70022.
PMID: 39624832
Silent cerebral infarcts (SCIs) are present in patients with sickle cell disease (SCD) and thalassemia, but the pathophysiology of SCIs is not fully understood. Previous studies mainly focused on cerebral...
7.
Konte K, Afzali-Hashemi L, Baas K, Schrantee A, Wood J, Nur E, et al.
Am J Hematol
. 2024 Nov;
100(1):78-84.
PMID: 39564863
Sickle cell disease (SCD) is complicated by silent cerebral infarcts (SCIs), for which anemia is an important risk factor. Despite normal oxygen delivery (OD), cerebral vascular reserve (CVR), and cerebral...
8.
Versluis J, Metzner M, Wang A, Gradowska P, Thomas A, Jakobsen N, et al.
J Clin Oncol
. 2024 Sep;
42(34):4084-4094.
PMID: 39231389
Purpose: AML is a genetically heterogeneous disease, particularly in older patients. In patients older than 60 years, survival rates are variable after the most important curative approach, intensive chemotherapy followed...
9.
Konte K, Swinkels D, Budde I, Nur E, Biemond B
Haematologica
. 2024 Sep;
110(1):183-186.
PMID: 39219461
No abstract available.
10.
Brandsen R, Biemond B, Nasim G, Nur E, Schlingemann R, Diederen R
Retina
. 2024 Aug;
44(12):2185-2195.
PMID: 39163633
Purpose: To evaluate macular abnormalities in sickle cell disease with optical coherence tomographic angiography and to determine associations with sickle cell retinopathy (SCR) and clinical and laboratory characteristics. Methods: Complete...